Lentiviral vectors with amplified β cell-specific gene expression

Gene Therapy

Volumn 16, Issue 8, 2009, Pages 998-1008

  Shaw, K L ^a   Pais, E ^a   Ge, S ^a   Hardee, C ^a   Skelton, D ^a   Hollis, R P ^a   Crooks, G M ^a,b   Kohn, D B ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; HUMAN INSULIN; LENTIVIRUS VECTOR; MESSENGER RNA; PHOSPHOGLYCERATE KINASE; PROTEIN VP16; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR GAL4;

ANIMAL CELL; ARTICLE; CELL LINE; CELL SPECIFICITY; CELL STRAIN HEK293; CELL STRAIN HT29; CELL STRAIN NIT 1; CONTROLLED STUDY; GENE AMPLIFICATION; GENE EXPRESSION; GENE FUSION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; REPORTER GENE; TWO STEP TRANSCRIPTION AMPLIFICATION SYSTEM; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL LINE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; LENTIVIRUS; MICE; ORGAN SPECIFICITY; PHOSPHOGLYCERATE KINASE; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION;

HUMAN HERPESVIRUS 1; MURINAE;

EID: 69249209723     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2009.49     Document Type: Article

References (30)

1. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (New York, NY) 2003; 302: 415-419.
2. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003; 348: 255-256.
3. Leibowitz G, Beattie GM, Kafri T, Cirulli V, Lopez AD, Hayek A et al Gene transfer to human pancreatic endocrine cells using viral vectors. Diabetes 1999; 48: 745-753.
4. Gallichan WS, Kafri T, Krahl T, Verma IM, Sarvetnick N. Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum Gene Ther 1998; 9: 2717-2726.
5. Ju Q, Edelstein D, Brendel MD, Brandhorst D, Brandhorst H, Bretzel RG et al. Transduction of non-dividing adult human pancreatic beta cells by an integrating lentiviral vector. Diabetologia 1998; 41: 736-739.
6. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. Development of a self-inactivating lentivirus vector. J Virol 1998; 72: 8150-8157.
7. Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L et al Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 1998; 72: 9873-9880.
8. Sadowski I, Ma J, Triezenberg S, Ptashne M. GAL4-VP16 is an unusually potent transcriptional activator. Nature 1988; 335: 563-564.
9. Emami KH, Carey M. A synergistic increase in potency of a multimerized VP16 transcriptional activation domain. EMBO J 1992; 11: 5005-5012.
10. Zhang L, Adams JY, Billick E, Ilagan R, Iyer M, Le K et al. Molecular engineering of a two-step transcription amplification (TSTA) system for transgene delivery in prostate cancer. Mol Ther 2002; 5: 223-232.
11. Sato M, Johnson M, Zhang L, Zhang B, Le K, Gambhir SS et al. Optimization of adenoviral vectors to direct highly amplified prostate-specific expression for imaging and gene therapy. Mol Ther 2003; 8: 726-737.
12. Iyer M, Salazar FB, Lewis X, Zhang L, Carey M, Wu L et al. Noninvasive imaging of enhanced prostate-specific gene expression using a two-step transcriptional amplification-based lentivirus vector. Mol Ther 2004; 10: 545-552.
13. Liu BH, Yang Y, Paton JF, Li F, Boulaire J, Kasparov S et al. GAL4-NF-kappaB fusion protein augments transgene expression from neuronal promoters in the rat brain. Mol Ther 2006; 14: 872-882.
14. Liu B, Paton JF, Kasparov S. Viral vectors based on bidirectional cell-specific mammalian promoters and transcriptional amplification strategy for use in vitro and in vivo. BMC Biotechnol 2008; 8: 49.
15. Zufferey R, Donello JE, Trono D, Hope TJ. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 1999; 73: 2886-2892.
16. Beattie GM, Lappi DA, Baird A, Hayek A. Functional impact of attachment and purification in the short term culture of human pancreatic islets. J Clin Endocrinol Metab 1991; 73: 93-98.
17. Odagiri H, Wang J, German MS. Function of the human insulin promoter in primary cultured islet cells. J Biol Chem 1996; 271: 1909-1915.
18. Segawa T, Takebayashi H, Kakehi Y, Yoshida O, Narumiya S, Kakizuka A. Prostate-specific amplification of expanded polyglutamine expression: A novel approach for cancer gene therapy. Cancer Res 1998; 58: 2282-2287.
19. Iyer M, Wu L, Carey M, Wang Y, Smallwood A, Gambhir SS. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc Natl Acad Sci USA 2001; 98: 14595-14600.
20. Qiao J, Doubrovin M, Sauter BV, Huang Y, Guo ZS, Balatoni J et al. Tumor-specific transcriptional targeting of suicide gene therapy. Gene Therapy 2002; 9: 168-175.
21. Koster RW, Fraser SE. Tracing transgene expression in living zebrafish embryos. Dev Biol 2001; 233: 329-346.
22. Iyer M, Salazar FB, Lewis X, Zhang L, Wu L, Carey M et al. Noninvasive imaging of a transgenic mouse model using a prostate-specific two-step transcriptional amplification strategy. Transgenic Res 2005; 14: 47-55.
23. Kadesch T, Berg P. Effects of the position of the simian virus 40 enhancer on expression of multiple transcription units in a single plasmid. Mol Cell Biol 1986; 6: 2593-2601.
24. Villemure JF, Savard N, Belmaaza A. Promoter suppression in cultured mammalian cells can be blocked by the chicken betaglobin chromatin insulator 5′HS4 and matrix/scaffold attachment regions. J Mol Biol 2001; 312: 963-974.
25. Hasegawa K, Nakatsuji N. Insulators prevent transcriptional interference between two promoters in a double gene construct for transgenesis. FEBS Lett 2002; 520: 47-52.
26. Logan AC, Haas DL, Kafri T, Kohn DB. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. J Virol 2004; 78: 8421-8436.
27. Kraunus J, Schaumann DH, Meyer J, Modlich U, Fehse B, Brandenburg G et al. Self-inactivating retroviral vectors with improved RNA processing. Gene Therapy 2004; 11: 1568-1578.
28. Higashimoto T, Urbinati F, Perumbeti A, Jiang G, Zarzuela A, Chang LJ et al. The woodchuck hepatitis virus post-transcriptional regulatory element reduces readthrough transcription from retroviral vectors. Gene Therapy 2007; 14: 1298-1304.
29. Wang X, Rosol M, Ge S, Peterson D, McNamara G, Pollack H et al. Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging. Blood 2003; 102: 3478-3482.
30. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997; 15: 871-875.